BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 18, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Cysview: Phase III data

A Phase III trial showed that using Cysview cystoscopy to detect non-muscle-invasive papillary cancer of the bladder resulted in a significant 16% relative reduction in tumor recurrence at 9 months following tumor resection compared with white light cystoscopy (47% vs. 56%, p=0.026). In 286...

Read the full 198 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >